MAP2K5 and acute myeloid leukemia: Importantly, the enzyme activity of Cot1, an upstream regulator of MEK5-ERK5-MEF2C, increases in AML cells during 1,25D-induced differentiation, as does phosphorylation of MEF2C, a downstream target of ERK5 [42,176] (Figure 3).